Amgen Reports Progress With Colorectal-cancer Drug - Wall Street Journal
Amgen Reports Progress With Colorectal-cancer DrugWall Street Journal... reported progress in a Phase III trial of Vectibix combined with the chemotherapy Folfox as a first-line treatment for metastatic colorectal cancer. ...cancer drug Erbitux extends life in one studyReutersAmgen Reports Positive Colon cancer Drug ResultsMarketNewsVideo.comMerck KGaA's Erbitux Drug Helps Colon cancer PatientsBloombergTrading Markets (press release)�-Wall Street Journal�-Wall Street Journalall 107 news articles��
Blog Marketing
Post a Comment